Back to search

Article

Νovel methylation biomarkers in liquid biopsy and classifying biosignatures for the clinical management of Breast Cancer

2025-06-19

Abstract excerpt

<title>Abstract</title> <p> Background Despite significant advancements, Breast Cancer (BrCa) remains a devastating disease presenting emerging needs for effective management. Recently, increasing attention has been given to epigenetic biomarkers assessed in liquid biopsy for diagnostic and prognostic applications. This study introduces a 3-step data-driven biomarker discovery pipeline, to identify robust methy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7cdca622-6f8f-56b3-9730-944459582195
DOI
10.21203/rs.3.rs-6697291/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Νovel methylation biomarkers in liquid biopsy and classifying biosignatures for the clinical management of Breast CancerDOI 10.21203/rs.3.rs-6697291/v1
DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?Semantic proximity
Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkersSemantic proximity
DNA methylation fingerprint for the diagnosis and monitoring of hepatocellular carcinoma from tissue and liquid biopsiesSemantic proximity
<em>BRAC1</em> & <em>BRCA2</em> Methylation as a Prognostic and Predictive Biomarker in Cancer: Implementation in Liquid Biopsy in the Era of Precision MedicineSemantic proximity
Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individualsSemantic proximity
DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsySemantic proximity
Discovery and validation of cell-free DNA methylation markers for specific diagnosis, differentiation from benign tumors, and prognosis of breast cancerSemantic proximity
Improving the clinical performance of blood-based DNA methylation biomarkers utilizing locus-specific epigenetic heterogeneitySemantic proximity
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer TypesSemantic proximity
DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsiesSemantic proximity
Development of methylation-based biomarkers for breast cancer detection by model training and validation in synthetic cell-free DNASemantic proximity
Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detectionSemantic proximity
Select a neighboring publication to make it the new centre.